MA
ZLAB icon

MYDA Advisors’s Zai Lab ZLAB Stock Holding History

MYDA Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,000
Closed -$255K – 187
2017
Q4 		$255K Buy
+12,000
New +$319K 0.11% 126

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

MYDA Advisors's ZLAB Position: Q1 2018 in Review

MYDA Advisors sold out of Zai Lab (ZLAB) in Q1 2018, closing a stake of 12,000 shares — an estimated $255K sold.

MYDA Advisors first reported a position in ZLAB in Q4 2017 and held it in 1 quarter. The position peaked at $255K in Q4 2017. 35 funds tracked by Wall St. Rank hold ZLAB as of Q1 2018.

  • MYDA Advisors reported no remaining Zai Lab position as of Q1 2018 after selling out during the quarter.
  • MYDA Advisors sold 12,000 Zai Lab shares in Q1 2018, an estimated $255K.
  • MYDA Advisors first reported a position in Zai Lab in Q4 2017 and held it in 1 quarter.
  • MYDA Advisors's Zai Lab position peaked at $255K in Q4 2017.
  • 35 funds tracked by Wall St. Rank held Zai Lab as of Q1 2018.

Based on MYDA Advisors's 13F filing for Q1 2018, filed 10 May 2018.